Your browser doesn't support javascript.
loading
Molecular monitoring during dose reduction predicts recurrence after TKI cessation in CML.
Gottschalk, Andrea; Glauche, Ingmar; Cicconi, Silvia; Clark, Richard E; Roeder, Ingo.
Affiliation
  • Gottschalk A; Institute for Medical Informatics and Biometry, Carl Gustav Carus Faculty of Medicine, Technische Universität Dresden, Dresden, Germany.
  • Glauche I; Institute for Medical Informatics and Biometry, Carl Gustav Carus Faculty of Medicine, Technische Universität Dresden, Dresden, Germany.
  • Cicconi S; Department of Molecular and Clinical Cancer Medicine and.
  • Clark RE; Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom; and.
  • Roeder I; Institute for Medical Informatics and Biometry, Carl Gustav Carus Faculty of Medicine, Technische Universität Dresden, Dresden, Germany.
Blood ; 135(10): 766-769, 2020 03 05.
Article in En | MEDLINE | ID: mdl-31935278
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Drug Monitoring / Molecular Diagnostic Techniques / Protein Kinase Inhibitors Type of study: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Blood Year: 2020 Type: Article Affiliation country: Germany
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Drug Monitoring / Molecular Diagnostic Techniques / Protein Kinase Inhibitors Type of study: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Blood Year: 2020 Type: Article Affiliation country: Germany